TissUse is a Berlin, Germany-based, vibrant growth company who has developed a unique "Multi-Organ-Chip" platform that - for the first time ever - provides ...
TissUse has developed a unique, proprietary and patent-protected “human-on-a-chip” technology platform to accelerate the development of pharmaceutical ...
TissUse provides a range of products which feature miniaturized constructs that closely simulate the activity of multiple human organs in their true physiological context ...
TissUse offers high-value service contracts to create custom solutions for safety evaluation of drugs, cosmetics and chemicals, and pre-clinical human ...
Meet TissUse at:
Please meet Dr. Katharina Schimek at Poster Board No. LB-027 on Sunday, March 31 from 1 pm - 5 pm:
Evaluation of EGFR induced on-target and target-mediated adverse effects in a 3D human lung tumour/skin microphysiological co-culture sytem
Location: Atlanta, Georgia, USA
Dr. Uwe Marx: Human Multi-Organ-Chip-based disease modelling: progress and challenges
Location: Cambridge, UK
Dr. Beren Atac-Wagegg: Microfluidic platforms for the future of Preclinical studies: Patient-on-a-Chip
Location: Rhodes, Greece